Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years.
about
Protecting the infant brain during cardiac surgery: a systematic reviewStress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology.Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgeryDesign and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery.Perioperative central nervous system injury in neonates.Anesthetic management for the pediatric patient undergoing deep hypothermic circulatory arrest.Brain monitoring and protection during pediatric cardiac surgery.Brain maturation is delayed in infants with complex congenital heart defectsEndocrinal complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease.Perioperative management of blood glucose during open heart surgery in infants and children.Critical illness hyperglycemia in pediatric cardiac surgery.Effects of peri-operative glucose levels on adverse outcomes in infants receiving open-heart surgery for congenital heart disease with cardiopulmonary bypass.Neuroprotective Drugs in Infants With Severe Congenital Heart Disease: A Systematic Review
P2860
Q26851482-510F928C-E032-43D0-96B4-5AAAB35A4A6CQ27003097-2B39F2BB-E71B-4C36-87C7-E28812A0BA73Q33734163-8D89168D-4B61-4F2A-802D-8EF3D680705DQ33941003-0F07D3BA-CA21-49EE-B702-572ECAE79CFBQ36335630-14A5EA0B-8A66-43A3-B5C8-815F9B16B779Q36465875-40B1FE2A-EA79-43F6-85B8-5783C9BB8D62Q36813061-70F0ACD9-7D8F-4D92-8C41-54ACCB476564Q36813065-9E29EF1E-8770-4B91-BB50-1E0ED7D6792CQ37241497-63DFB480-EBB9-4BCC-B207-FD34B0ADEB7DQ37343546-17C9C09E-D62B-4A6F-8759-D46F77404C9CQ37863730-97DE2F63-0862-4195-AFC3-31658C198BFAQ37991761-D0C0E741-9CD1-4371-8803-57B1E68811B9Q39816946-62F8A69B-02AA-426D-9A35-0566514FFD7BQ57177295-1E9ABEA6-3B3C-4C31-BA31-5D2F9995928C
P2860
Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Intraoperative hyperglycemia d ...... outcomes at 1, 4, and 8 years.
@ast
Intraoperative hyperglycemia d ...... outcomes at 1, 4, and 8 years.
@en
type
label
Intraoperative hyperglycemia d ...... outcomes at 1, 4, and 8 years.
@ast
Intraoperative hyperglycemia d ...... outcomes at 1, 4, and 8 years.
@en
prefLabel
Intraoperative hyperglycemia d ...... outcomes at 1, 4, and 8 years.
@ast
Intraoperative hyperglycemia d ...... outcomes at 1, 4, and 8 years.
@en
P2093
P50
P1433
P1476
Intraoperative hyperglycemia d ...... outcomes at 1, 4, and 8 years.
@en
P2093
Adre du Plessis
David C Bellinger
Paul R Hickey
Peter C Laussen
Richard A Jonas
Sarah de Ferranti
P304
P356
10.1097/00000542-200406000-00005
P407
P577
2004-06-01T00:00:00Z